Skip to main content
SpringerLink
Log in

Irbesartan in patients with heart failure and preserved ejection fraction

  • Clinical Trials Report
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003, 362:777–781.

    Article  PubMed  CAS  Google Scholar 

  2. Vasan RS, Larson MG, Benjamin EJ, et al.: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999, 33:1948–1955.

    Article  PubMed  CAS  Google Scholar 

  3. Owan TE, Hodge DO, Herges RM, et al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251–259.

    Article  PubMed  CAS  Google Scholar 

  4. Bhatia RS, Tu JV, Lee DS, et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260–269.

    Article  PubMed  CAS  Google Scholar 

  5. Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004, 350:1953–1959.

    Article  PubMed  CAS  Google Scholar 

  6. Kitzman DW, Gardin JM, Gottdiener JS, et al.: Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001, 87:413–419.

    Article  PubMed  CAS  Google Scholar 

  7. Kitzman DW, Little WC, Brubaker PH, et al.: Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002, 288:2144–2150.

    Article  PubMed  Google Scholar 

  8. Liao L, Jollis JG, Anstrom KJ, et al.: Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med 2006, 166:112–118.

    Article  PubMed  Google Scholar 

  9. Westermann D, Kasner M, Steendijk P, et al.: Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008, 117:2051–2060.

    Article  PubMed  Google Scholar 

  10. Kitzman DW, Higginbotham MB, Cobb FR, et al.: Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991, 17:1065–1072.

    Article  PubMed  CAS  Google Scholar 

  11. Sciarretta S, Paneni F, Palano F, et al.: Role of the reninangiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Science (London) 2009, 116:467–477.

    CAS  Google Scholar 

  12. Cleland JG, Tendera M, Adamus J, et al.: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006, 27:2338–2345.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, USA

    Daniel Forman

  2. VA Boston Healthcare System, Boston, USA

    Daniel Forman

  3. 75 Francis Street, Boston, MA, 02494, USA

    Daniel Forman

  4. Division of Aging, Brigham and Women’s Hospital, Boston, USA

    J. Michael Gaziano

  5. 1620 Tremont Street, Boston, MA, 02120, USA

    J. Michael Gaziano

Authors
  1. Daniel Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Michael Gaziano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Forman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forman, D., Gaziano, J.M. Irbesartan in patients with heart failure and preserved ejection fraction. Curr Cardio Risk Rep 3, 311–312 (2009). https://doi.org/10.1007/s12170-009-0056-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-009-0056-1

Keywords

Search

Navigation